Today, the European Commission awarded the 2017 European Capital of Innovation (iCapital) prize of €1,000,000 to Paris. The award, granted under the EU's research and innovation programme Horizon 2020, recognises Paris for its inclusive innovation strategy. Tel Aviv and Tallinn were selected as runners-up, and were both awarded €100,000.
In the face of this ongoing epidemic that has already claimed too many lives, and for which there is still no cure, the Commission remains at the forefront in the fight against HIV/AIDS. This is done for example through funding research and innovation via Horizon 2020 where € 73 million have already been invested during the first two years of the programme.
The ERC has today opened the next competition for its Consolidator Grants. More than €600 million is earmarked for an estimated 335 grants. The deadline for submission of research proposals is 2 February 2016.
Carlos Moedas, Commissioner for Research, Science and Innovation said: "Research and innovation are the engines of Europe's progress and vital to addressing today's new pressing challenges like immigration, climate change, clean energy and healthy societies. Over the next two years, €16 billion from Horizon 2020 will support Europe's top scientific efforts, making the difference to citizens' lives."
The European Commission adopted yesterday the ERC Work Programme 2016.
The programme foresees €1.67 billion for grants to top researchers.
Within the new series of competitions, the ERC has opened today the first one, the call for Starting
Grants 2016, with a budget of €485 million and deadline of 17 November 2015. This scheme is open
to researchers with 2 to 7 years of experience since completion of PhD and a promising scientific
Researchers, businesses and innovators from Ukraine will now be able to fully participate in Horizon 2020, the European Union's research and innovation funding programme, on equal terms with EU Member States and other associated countries.
The European Research Council (ERC) is today announcing the 372 winners of its second Consolidator Grant competition. These excellent mid-career scientists are awarded a total of €713 million, as part of the European Union Research and Innovation programme Horizon 2020. Grants are worth up to €2.75 million each, with an average of €1.91 million per grant. The funding will enable them to consolidate their research teams and to develop their most innovative ideas.
The European Commission is today announcing eight research projects into Ebola that will be funded with a total of €215 million. These projects will develop vaccines and rapid diagnostic tests, which are key to overcoming the current Ebola crisis.
The projects are run under the new Ebola+ programme of the Innovative Medicines Initiative (IMI) and funded jointly by the European Commission and the European pharmaceutical industry.